{"entity":{"type":"insider","cik":"0001865844","url":"/insider/0001865844","json_url":"/insider/0001865844.json","name":"Longitude Prime Fund, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2021-07-20","last":"2026-02-06","span_basis":"filed_date"},"name_variants":[{"name":"Longitude Prime Fund, L.P.","source":"filing","n_filings":4,"first_seen":"2021-07-20","last_seen":"2026-02-06"}],"transactions":[{"id":6036226,"accession":"0001193125-26-041248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-041248","line_url":"/filing/0001193125-26-041248#line-1","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","issuer_ticker":"RPID","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Fund, L.P.; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49000.0,"shares_display":"49,000","price_per_share":3.8794,"price_display":"3.88","price_state":"stated","total_value":190090.6,"total_display":"190,090.60","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-06","scope":"insider"},{"id":7799552,"accession":"0000899243-23-004349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-004349","line_url":"/filing/0000899243-23-004349#line-1","is_derivative":false,"issuer_cik":"0001431159","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001431159","owner_cik":null,"owner_name":"Tammenoms Bakker Juliet; Longitude Prime Fund, L.P.; Longitude Capital Partners IV, LLC; Longitude Prime Partners, LLC; Longitude Venture Partners IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1714285.0,"shares_display":"1,714,285","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":11999995.0,"total_display":"11,999,995.00","shares_owned_after":1714285.0,"shares_owned_after_display":"1,714,285","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":6531980,"accession":"0000899243-22-004271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-004271","line_url":"/filing/0000899243-22-004271#line-1","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Prime Fund, L.P.; Longitude Prime Partners, LLC; ENRIGHT PATRICK G; Tammenoms Bakker Juliet; Longitude Venture Partners III, L.P.; Longitude Capital Partners III, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":175000.0,"shares_display":"175,000","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":4725000.0,"total_display":"4,725,000.00","shares_owned_after":175000.0,"shares_owned_after_display":"175,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-02","scope":"insider"},{"id":4305930,"accession":"0000899243-21-029105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-029105","line_url":"/filing/0000899243-21-029105#line-2","is_derivative":false,"issuer_cik":"0001253886","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","issuer_ticker":"RPID","issuer_name_source":null,"issuer_url":"/issuer/0001253886","owner_cik":null,"owner_name":"Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; ENRIGHT PATRICK G; Longitude Prime Fund, L.P.; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":150000.0,"shares_owned_after_display":"150,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-19","filed_date":"2021-07-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001380106","name":"RAPID MICRO BIOSYSTEMS, INC.","url":"/issuer/0001380106","role":"Ten percent owner","n_filings":2,"first_seen":"2021-07-20","last_seen":"2026-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001831828","name":"Vera Therapeutics, Inc.","url":"/issuer/0001831828","role":"Ten percent owner","n_filings":1,"first_seen":"2023-02-08","last_seen":"2023-02-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Ten percent owner","n_filings":1,"first_seen":"2022-02-02","last_seen":"2022-02-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001865844","retrieved_at":"2026-08-21T03:51:27+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}